Projects

Evaluating the role of key serum biomarkers in the Prognosis of suspected multiple myeloma in a tertiary care hospital

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - Ongoing

Project Lead

Mr Saikat Sen

Authors

Mr Saikat Sen, Dr Jyothi D N, Dr Shbha N Prakash

Project Status

ongoing

Project Type

Mr Saikat Sen